The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers


ELLİDOKUZ E. B., Kaya D.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.18, sa.1, ss.151-155, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

Özet

Background: Metoclopramide, a central and peripheral dopamine type 2 receptor antagonist, has been used as an attractive and safer alternative to cisapride. However, cardiac side-effects have also been reported with this drug.